The Lancet Psychiatry
April 5, 2016
Michael C Mithoefer, Charles S. Grob, Timothy D Brewerton
237 citations
4-phosphorloxy-N,N-dimethyltryptamine (psilocybin) and methylenedioxymethamfetamine (MDMA), best known for their illegal use as psychedelic drugs, are showing promise as therapeutics in a resurgence of clinical research during the past 10 years. Psilocybin is being tested for alcoholism, smoking cessation, and in patients with advanced cancer with anxiety. MDMA is showing encouraging results as...
Clinical Psychology Review
April 1, 2016
M.P.J. Spijkerman, Wendy T. M. Pots, Ernst T. Bohlmeijer
Mindfulness-based interventions (MBIs) are increasingly being delivered through the Internet. Whereas numerous meta-analyses have investigated the effectiveness of face-to-face MBIs in the context of mental health and well-being, thus far a quantitative synthesis of the effectiveness of online MBIs is lacking. The aim of this meta-analysis was to estimate the overall effects of online MBIs on...
World Journal of Clinical Cases
April 1, 2016
Kirtigandha Salwe Carter, Robert Carter
Stress can be associated with many physiological changes resulting in significant decrements in human performance. Due to growing interests in alternative and complementary medicine by Westerners, many of the traditions and holistic yogic breathing practices today are being utilized as a measure for healthier lifestyles. These state-of-the-art practices can have a significant impact on common...
Scientia et technica
March 30, 2016
Carlos Diego Ferrín Bolaños, Esteban Mauricio Correa Agudelo, Andres Mauricio Hernandez Camacho et al.
Meditation benefits have been widely supported by many research works. It is considered a natural way of reducing stress, depression, and other anxiety disorders. However, meditation process is a breathe pursuing task that requires long time training to avoid the so-called mind wandering. In this work, we propose a neural-feedback system that detects when mind wanders and generates an audible...
Therapeutic Advances in Psychopharmacology
March 23, 2016
Saibal Das, Preeti Barnwal, Anand Ramasamy et al.
51 citations
Lysergic acid diethylamide (LSD), described as a classical hallucinogen, began its journey from the middle of the last century following an accidental discovery. Since then, it was used as a popular and notorious substance of abuse in various parts of the world. Its beneficial role as an adjunct to psychotherapy was much unknown, until some 'benevolent' experiments were carried out over time to...
Zebrafish
March 22, 2016
Evan J. Kyzar, Allan V. Kalueff
29 citations
After decades of sociopolitical obstacles, the field of psychiatry is experiencing a revived interest in the use of hallucinogenic agents to treat brain disorders. Along with the use of ketamine for depression, recent pilot studies have highlighted the efficacy of classic serotonergic hallucinogens, such as lysergic acid diethylamide and psilocybin, in treating addiction, post-traumatic stress...
Psychodynamic psychiatry
March 2016
Myron L Glucksman
Freud's "Project for a Scientific Psychology" (1895) reflected his attempt to explain psychic phenomena in neurobiological terms. The recent discovery of the neuron motivated him to embark on this endeavor. His basic hypothesis was that neurons were vehicles for the conduction of "currents" or "excitations," and that they were connected to one another. Using this model, Freud attempted to...
JBI database of systematic reviews and implementation reports
March 2016
Kishani Townshend, Zoe Jordan, Matthew Stephenson et al.
The rationale for undertaking this review was to investigate a potential strategy to address the rising prevalence of child and adolescent mental health disorders. The central tenants of mindful parenting appear to be emotional awareness, emotional regulation, attention regulation, intentionality and non-judgmental acceptance. The primary objective of this review was to systematically evaluate...
Inflammatory bowel diseases
March 2016
Kate Neilson, Maria Ftanou, Kaveh Monshat et al.
This study aimed to evaluate the feasibility, acceptability, and effectiveness of a mindfulness-based intervention for patients with inflammatory bowel disease (MI-IBD). Treatment-as-usual control versus mindfulness-based stress reduction intervention. Sixty patients participated in either the MI-IBD (n = 33) or treatment-as-usual group (n = 27) conditions. The MI-IBD consisted of an 8-week...
BJPsych Open
March 1, 2016
Akshya Vasudev, Amanda Arena, A. Burhan et al.
Retracted
Late-life depression affects 2–6% of seniors aged 60 years and above. Patients are increasingly embracing non-pharmacological therapies, many of which have not been scientifically evaluated. This study aimed to evaluate a category of meditation, automatic self-transcending meditation (ASTM), in alleviating symptoms of depression when augmenting treatment as usual (NCT02149810). The preliminary...